Form 4 for WST West Pharmaceutical Services
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001562180-22-001905 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-24 | 2022-02-22 | WST | Lai Quintin J | VP Corp Development, Strategy | A - Grant | $369.13 | +3,138 | 5,372 | +140% | +$1.16M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | A | A | 3,138 | $369.13 | 5,371.84 | D | — | — | (F1) 2019 PSUs (PP18) award vesting net of taxes withheld. The net shares were deferred as deferred stock units in the Non-Qualified Deferred Compensation (NQDC) plan for employees to be distributed in accordance with the terms of the NQDC plan and their individual elections |